A detailed history of Nichols & Pratt Advisers LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 36,862 shares of ABT stock, worth $3.8 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
36,862
Previous 37,396 1.43%
Holding current value
$3.8 Million
Previous $4.12 Million 1.77%
% of portfolio
0.29%
Previous 0.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$109.52 - $120.96 $58,483 - $64,592
-534 Reduced 1.43%
36,862 $4.19 Million
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $194,630 - $238,243
-2,158 Reduced 5.46%
37,396 $4.12 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $28,659 - $34,386
300 Added 0.76%
39,554 $3.83 Million
Q2 2023

Aug 02, 2023

SELL
$100.78 - $112.29 $98,260 - $109,482
-975 Reduced 2.42%
39,254 $4.28 Million
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $326,902 - $384,783
3,375 Added 9.16%
40,229 $4.07 Million
Q4 2022

Feb 03, 2023

BUY
$95.06 - $111.52 $43,442 - $50,964
457 Added 1.26%
36,854 $4.05 Million
Q3 2022

Nov 01, 2022

SELL
$96.76 - $112.03 $557,337 - $645,292
-5,760 Reduced 13.66%
36,397 $3.52 Million
Q2 2022

Aug 04, 2022

BUY
$102.07 - $123.37 $67,162 - $81,177
658 Added 1.59%
42,157 $4.58 Million
Q1 2022

May 10, 2022

SELL
$114.02 - $139.04 $17,103 - $20,856
-150 Reduced 0.36%
41,499 $4.91 Million
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $9,820 - $12,024
85 Added 0.2%
41,649 $5.86 Million
Q3 2021

Nov 01, 2021

SELL
$116.66 - $129.06 $1,166 - $1,290
-10 Reduced 0.02%
41,564 $4.87 Million
Q2 2021

Aug 09, 2021

BUY
$105.79 - $124.53 $52,895 - $62,265
500 Added 1.22%
41,574 $4.82 Million
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $29,386 - $34,622
-270 Reduced 0.65%
41,074 $4.92 Million
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $259,350 - $282,617
-2,470 Reduced 5.64%
41,344 $4.53 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $27,492 - $33,387
300 Added 0.69%
43,814 $4.77 Million
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $730,094 - $934,430
-9,535 Reduced 17.97%
43,514 $3.98 Million
Q1 2020

Apr 24, 2020

BUY
$62.82 - $91.86 $193,171 - $282,469
3,075 Added 6.15%
53,049 $4.19 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $720,957 - $802,594
-9,183 Reduced 15.52%
49,974 $4.34 Million
Q3 2019

Nov 07, 2019

SELL
$81.84 - $88.74 $96,898 - $105,068
-1,184 Reduced 1.96%
59,157 $4.95 Million
Q2 2019

Aug 05, 2019

SELL
$72.88 - $85.0 $19,240 - $22,440
-264 Reduced 0.44%
60,341 $5.08 Million
Q1 2019

Apr 30, 2019

BUY
$66.22 - $80.06 $1,258 - $1,521
19 Added 0.03%
60,605 $4.85 Million
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $70,477 - $79,840
-1,075 Reduced 1.74%
60,586 $4.38 Million
Q3 2018

Nov 05, 2018

SELL
$60.81 - $73.36 $171,788 - $207,242
-2,825 Reduced 4.38%
61,661 $4.52 Million
Q2 2018

Jul 27, 2018

BUY
$57.57 - $63.54 $20,149 - $22,239
350 Added 0.55%
64,486 $3.93 Million
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $416,288 - $445,679
-7,755 Reduced 10.79%
64,136 $3.66 Million
Q3 2017

Nov 08, 2017

SELL
$48.06 - $53.64 $14,418 - $16,092
-300 Reduced 0.42%
71,891 $3.84 Million
Q2 2017

Aug 08, 2017

BUY
N/A
72,191
72,191 $3.51 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $180B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nichols & Pratt Advisers LLP Portfolio

Follow Nichols & Pratt Advisers LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.